ARTICLE | Product Development
U.K. BIA Antibody Taskforce picks COVID-19 mAb cocktail candidates
October 31, 2020 1:16 AM UTC
The U.K. BIA Antibody Taskforce is gearing up to start human testing of its cocktails of antiviral COVID-19 mAbs as FDA’s decisions on EUAs are pending for Regeneron’s mAb cocktail and a mAb monotherapy from Lilly.
The task force said its mAb cocktails are differentiated from other antiviral mAb cocktails in development...